brilliant move by frost
PROLOR, with PROLOR continuing as the surviving corporation and a wholly-owned subsidiary of OPKO (the “Merger”).
Not sure but it looks like we fold all our biopharma phase 1-2-3 programs into a newly formed opk division called prolor biotech.
It is basically a 1:1 stock deal, .9951 shares opk for every pbth.
This is a merger that benefits PBTH share holders big time.